Does Kratom Interact With Ondansetron (Zofran)?
Yes. Ondansetron does not elicit any psychotropic effects and, as such, will not interfere with kratom’s properties.
However, these compounds do have a metabolic interaction.
The inhibition of ondansetron’s metabolization will increase the likelihood of adverse effects.
Is it Safe to Take Kratom With Ondansetron (Zofran)?
No, the metabolic interaction between kratom and antiemetics like ondansetron carries a mild to moderate risk.
When it comes to metabolic inhibition, if you only plan to take ondansetron once, then concomitant use with kratom will likely not result in significant risk. If you must use ondansetron daily, this will increase the risk factor considerably.
In order to stay safe, it’s best to avoid this combination or talk to your doctor first. Since ondansetron is used mainly when the patient is undergoing severe nausea, and other negative symptoms, abstaining from kratom should not be difficult.
Ondansetron — sold under the brand name Zofran — is a prescription-only antiemetic medication.
There are several types of antiemetics.
Ondansetron is a serotonin 5-HT3 receptor antagonist and functions by blocking serotonin receptors in the central nervous system and the gastrointestinal tract. This inhibits the action of serotonin — a natural substance that has a role in causing nausea and vomiting. It is available by tables, film, oral solution, and injection into a muscle or vein.
|CYP Metabolism||Predominantly cleared by 3A4 and 2D6; 1A2 is also involved|
|Interaction With Kratom||Kratom inhibits the metabolization of ondansetron|
|Risk of Interaction||Moderate|
What Is Ondansetron Used for?
The FDA has approved ondansetron for the following indications:
- Nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy (including cisplatin)
- Postoperative nausea or vomiting
- Nausea and vomiting associated with radiotherapy in patients receiving either total body radiation, a single high-dose fraction to the abdomen, or daily fractions to the abdomen
Ondansetron also has several off-label uses (not approved by the FDA):
- Treatment of morning sickness and hyperemesis gravidarum during pregnancy 
- Cyclic vomiting syndrome
- Reduction of vomiting as associated with gastroenteritis 
Ondansetron is available under the following brand names:
The recommended dose of ondansetron varies based on the ailment and the user’s age. The FDA recommends the following:
- Highly emetogenic chemotherapy: A single 24-mg dose administered 30 minutes before the start of single-day highly emetogenic chemotherapy, including cisplatin greater than or equal to 50 mg/m2
- Moderately emetogenic chemotherapy: 8 mg administered 30 minutes before the start of chemotherapy, with a subsequent 8-mg dose 8 hours after the first dose
- Radiotherapy: usually 8 mg
- Postoperative: 16 mg administered 1 hour before induction of anesthesia.
- Moderately emetogenic chemotherapy:
- (12-17): 8 mg administered 30 minutes before the start of chemotherapy, with a subsequent 8-mg dose 4 and 8 hours after the first dose.
- (4-11): 4 mg administered 30 minutes before the start of chemotherapy, with a subsequent 4-mg dose 4 and 8 hours after the first dose
There is little clinical data on the use of ondansetron on people under 4 years of age. No recommended doses can be given in these instances.
Those with severe hepatic impairment should not exceed a daily dose of 8 mg.
The most common adverse effects of ondansetron use are :
- Abdominal pain
Serious side effects include:
- QT prolongation
- Severe allergic reaction
- Serotonin syndrome
There are also contraindications to taking ondansetron:
- Patients with a hypersensitivity to ondansetron or its components
- Concomitant use of apomorphine
The use of ondansetron during pregnancy carries a low risk of harm to the baby and entails an increased risk of heart problems .
Kratom is the all-natural plant compound derived from the leaves of the Mitragyna speciosa, a tropical evergreen tree native to Southeast Asia.
Local indigenous peoples have used kratom for many centuries to aid them in their day-to-day tasks and as medicine. Now, the western hemisphere is finally noticing the many benefits of the plant.
Kratom’s effects are due to the many plant-based alkaloids it contains. These compounds interact with the opioid receptors in the body’s central nervous system to produce a range of effects.
Nevertheless, despite its many favorable properties, kratom can be addictive and has contributed to overdose deaths in the United States. However, this is rare and almost always the result of interactions with other drugs.
The effects of kratom depend on the amount ingested.
A lower dose promotes nootropic, mind-based effects like increased mental energy and mood-enhancing properties. Higher doses lead to more analgesic and sedative-like effects — ideal for chronic pain and relaxation.
Essentially, kratom’s many properties help treat numerous ailments, but they can also serve as nootropic supplements.
Only time will tell what other uses for kratom there are.
It’s crucial to get your kratom dosage right.
As we’ve just seen, the effects of the kratom plant are highly dependent on dosage. If you want to make the best out of your kratom experience, then choose the proper dosage for the job.
- Low dose (1 – 5 g): Produces nootropic and stimulant effects such as increased mental functioning and euphoria.
- Medium dose (5 – 10 g): Analgesic and anxiolytic properties become more evident at this range.
- High dose (10 – 15 g): heavy doses of kratom provide strong pharmacological benefits and potent sedative-like effects.
Remember that everyone’s bodies are different, and formulaic dosage recommendations are generally best avoided.
Kratom and opioid medications have roughly the same side effects. However, kratom’s adverse effects are usually much less severe.
Kratom’s common side effects are:
More severe side effects include:
There are four different kratom strains: this is excellent news for you if you’re the type of person who likes to personalize their experience!
These strains all have the same basic properties, but each one emphasizes certain effects.
Familiarize yourself with the different strains if you’re looking to take kratom for a specific purpose — it will help you get the most bang for your buck.
White-veined kratom strains fall under the mind-based spectrum of kratom benefits. They stimulate mental focus, euphoria, and generalized states of increased mental activity.
If you’re looking to try kratom for its stimulant-like properties, white strains are likely your best option.
Red vein kratom strains are the ideal option for anyone experiencing chronic pain but don’t want pharmacological pain killers.
Red vein kratom also has anxiolytic benefits, and it’s popularly used as sleep support since it promotes calm and relaxation.
Green vein kratom sits right between white and red in the kratom spectrum.
This means that green-veined strains have a balanced alkaloid profile that contains both the analgesic and anxiolytic properties, as well as the mind-based effects.
However, this means that you won’t experience the targeted nature of a white or red kratom strain.
Yellow vein kratom is thought to be a mixture of red and white strains. For this reason, it is generally not considered to be one of the three main types of kratom.
Yellow vein users report this strain is comparable to green kratom strains but with more mild effects.
Not necessarily. Due to their metabolic interaction, there’s an increased risk of adverse effects. It’s best to talk to your doctor before using kratom with ondansetron.
The main factor you have to keep in mind is that kratom consumption will lead to higher levels of ondansetron in the body due to its inhibitory metabolic effect. Luckily, ondansetron’s elimination half-life is relatively short (around 5 hours).
If you feel like you must continue using both compounds, then try to space them out and consult your doctor about what other alternatives are open to you.
- Saynor, D. A., & Dixon, C. M. (1989). The metabolism of ondansetron. European journal of cancer & clinical oncology, 25, S75-7.
- Hanapi, N. A., Ismail, S., & Mansor, S. M. (2013). Inhibitory effect of mitragynine on human cytochrome P450 enzyme activities. Pharmacognosy research, 5(4), 241.
- Siminerio, L. L., Bodnar, L. M., Venkataramanan, R., & Caritis, S. N. (2016). Ondansetron use in pregnancy. Obstetrics and gynecology, 127(5), 873.
- Freedman, S. B., Adler, M., Seshadri, R., & Powell, E. C. (2006). Oral ondansetron for gastroenteritis in a pediatric emergency department. New England Journal of Medicine, 354(16), 1698-1705.
- Bryson, J. C. (1992, December). Clinical safety of ondansetron. In Seminars in oncology (Vol. 19, No. 6 Suppl 15, pp. 26-32).
- Carstairs, S. D. (2016). Ondansetron use in pregnancy and birth defects: a systematic review. Obstetrics & Gynecology, 127(5), 878-883.